Thailanstatin Analogs (Akari Therapeutics)

N/A

Report date: 2026/04/28 20:00:22

Base Information

Drug NameThailanstatin Analogs (Akari Therapeutics)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > PH1 payload

Mechanisms of ActionRNA splicing modulators

TargetsUpdating

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAkari Therapeutics Plc

China Registration ClassN/A

Develop Information

Active CompaniesAkari Therapeutics Plc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A